Fc receptor binding proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8815246
APP PUB NO 20130078262A1
SERIAL NO

13617498

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bitonti, Alan J Acton, US 63 1803
Dumont, Jennifer Groton, US 13 102
Ladner, Robert Charles Ijamsville, US 83 1648
Liu, Liming Upper Dublin, US 58 198
McDonnell, Kevin Waltham, US 56 961
Muruganandam, Arumugam Bangalore, IN 28 355
Sato, Aaron K Richmond, US 45 785
Stattel, James Hagerstown, US 8 366
TenHoor, Christopher Hopkinton, US 23 172
Viswanathan, Malini Burlington, US 39 321
Wood, Clive Boston, US 31 1231

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 26, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00